These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32914393)

  • 1. Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's Disease.
    Stazi M; Wirths O
    Mol Neurobiol; 2021 Jan; 58(1):204-216. PubMed ID: 32914393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis.
    Stazi M; Lehmann S; Sakib MS; Pena-Centeno T; Büschgens L; Fischer A; Weggen S; Wirths O
    Cell Mol Life Sci; 2021 Dec; 79(1):55. PubMed ID: 34913091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine.
    Xiao H; Li H; Song H; Kong L; Yan X; Li Y; Deng Y; Tai H; Wu Y; Ni Y; Li W; Chen J; Yang J
    J Ethnopharmacol; 2020 Sep; 259():112957. PubMed ID: 32416248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages.
    Devi L; Ohno M
    Pharmacol Biochem Behav; 2016 May; 144():60-6. PubMed ID: 26948858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging.
    Scholtzova H; Wadghiri YZ; Douadi M; Sigurdsson EM; Li YS; Quartermain D; Banerjee P; Wisniewski T
    J Neurosci Res; 2008 Sep; 86(12):2784-91. PubMed ID: 18615702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
    Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J
    Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456
    [No Abstract]   [Full Text] [Related]  

  • 8. Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal-CA1 projection.
    Li P; Xu J; Gu H; Peng H; Yin Y; Zhuang J
    BMC Neurosci; 2021 Jun; 22(1):41. PubMed ID: 34120588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
    Chen TF; Huang RF; Lin SE; Lu JF; Tang MC; Chiu MJ
    J Alzheimers Dis; 2010; 20(2):607-15. PubMed ID: 20164552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
    Jürgenson M; Zharkovskaja T; Noortoots A; Morozova M; Beniashvili A; Zapolski M; Zharkovsky A
    J Pharm Pharmacol; 2019 Nov; 71(11):1695-1705. PubMed ID: 31531878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice.
    Cotel MC; Jawhar S; Christensen DZ; Bayer TA; Wirths O
    Neurobiol Aging; 2012 Jan; 33(1):96-107. PubMed ID: 20359774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-β3-42.
    Meißner JN; Bouter Y; Bayer TA
    J Alzheimers Dis; 2015; 45(2):471-82. PubMed ID: 25547635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.
    Couly S; Denus M; Bouchet M; Rubinstenn G; Maurice T
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):142-157. PubMed ID: 32977336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration.
    Borre Y; Bosman E; Lemstra S; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Apr; 62(5-6):2010-7. PubMed ID: 22248638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent enhancement of hippocampus-dependent memory after treatment with memantine: Implications for enhanced hippocampal adult neurogenesis.
    Ishikawa R; Kim R; Namba T; Kohsaka S; Uchino S; Kida S
    Hippocampus; 2014 Jul; 24(7):784-93. PubMed ID: 24599753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model.
    Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B
    Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR40 receptor activation leads to CREB phosphorylation and improves cognitive performance in an Alzheimer's disease mouse model.
    Khan MZ; Zhuang X; He L
    Neurobiol Learn Mem; 2016 May; 131():46-55. PubMed ID: 26976092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of hippocampal markers of synaptic plasticity by memantine in animal models of acute and repeated restraint stress: implications for memory and behavior.
    Amin SN; El-Aidi AA; Ali MM; Attia YM; Rashed LA
    Neuromolecular Med; 2015 Jun; 17(2):121-36. PubMed ID: 25680935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.